Masanori Kotake

Blood Perfusion Assessment by Indocyanine Green Fluorescence Imaging for Minimally Invasive Rectal Cancer Surgery (EssentiAL trial)

Jun Watanabe, Ichiro Takemasa, Masanori Kotake et al. · Annals of Surgery · 2023 · 156 citations · Full text

Medicine, Oncology, Surgery +17

Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial

Hideki Ueno, Megumi Ishiguro, Eiji Nakatani et al. · Journal of Clinical Oncology · 2019 · 149 citations · Full text

Medicine, Oncology, Surgery +17

S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer (TRICOLORE): a randomized, open-label, phase III, noninferiority trial

Yasuhide Yamada, Tadamichi Denda, Makio Gamoh et al. · Annals of Oncology · 2017 · 91 citations · Full text

Medicine, Oncology, Pharmacology +10

A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial

Chu Matsuda, Megumi Ishiguro, Satoshi Teramukai et al. · European Journal of Cancer · 2018 · 82 citations · Full text

Medicine, Oncology, Surgery +16

A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)

Eiji Oki, Akihiko Murata, Kazuhiro Yoshida et al. · Annals of Oncology · 2016 · 55 citations · Full text

Medicine, Oncology, Pharmacotherapy +16